33986239|t|Convexal Subarachnoid Hemorrhage Caused by Infective Endocarditis in a Patient with Advanced Human Immunodeficiency Virus (HIV): The Culprits and Bystanders.
33986239|a|BACKGROUND Convexal subarachnoid hemorrhage (cSAH), a rare form of non-aneurysmal subarachnoid hemorrhage, is confined to cerebral convexities without extension into basal cisterns or ventricles. Typical presentation includes thunderclap/progressive headache or transient focal neurological symptoms; rare manifestations include seizures, intractable vomiting, or altered mental status. Here, we report the first case of convexal subarachnoid hemorrhage and multifocal ischemic lesions caused by infective endocarditis (IE) in a treatment-naive advanced HIV patient. CASE REPORT A 52-year-old HAART-naive, HIV-positive, African American man presented with altered mental status, shortness of breath, nonproductive cough, and generalized weakness. His past medical history was significant for congestive heart failure, chronic obstructive pulmonary disease, and end-stage renal disease (noncompliant with hemodialysis). Head computed tomography (CT) showed an isolated sulcal hemorrhage in the mid-left frontal lobe. Fluid-attenuated inversion recovery/gradient recalled echo sequences confirmed a hemorrhage in the left-mid-frontal sulcus, and diffusion-weighted imaging revealed multifocal bilateral ischemic lesions. Transesophageal echocardiography exhibited mitral valve vegetations. Multifocal ischemic lesions and cSAH caused by infectious endocarditis were confirmed. Initiation of intravenous vancomycin and piperacillin-tazobactam allowed the patient to have resolution of his altered mental status. A head CT 5 days later revealed the resolution of cSAH. CONCLUSIONS Infective endocarditis should be considered as an underlying etiology of cSAH, especially when present with multifocal ischemic lesions. Risk factors contributing to the development of cSAH in the IE patient population should be explored in future studies. HIV has not been previously reported in this subgroup and its prevalence should be considered. The prognosis for cSAH in relation to IE is generally favorable.
33986239	0	32	Convexal Subarachnoid Hemorrhage	Disease	MESH:D013345
33986239	43	65	Infective Endocarditis	Disease	MESH:D004696
33986239	71	78	Patient	Species	9606
33986239	93	121	Human Immunodeficiency Virus	Species	12721
33986239	123	126	HIV	Species	12721
33986239	169	201	Convexal subarachnoid hemorrhage	Disease	MESH:D013345
33986239	203	207	cSAH	Disease	MESH:D013345
33986239	229	263	aneurysmal subarachnoid hemorrhage	Disease	MESH:D013345
33986239	384	395	thunderclap	Disease	MESH:D051270
33986239	408	416	headache	Disease	MESH:D006261
33986239	430	457	focal neurological symptoms	Disease	MESH:D009461
33986239	487	495	seizures	Disease	MESH:D012640
33986239	509	517	vomiting	Disease	MESH:D014839
33986239	579	611	convexal subarachnoid hemorrhage	Disease	MESH:D013345
33986239	627	643	ischemic lesions	Disease	MESH:D017202
33986239	654	676	infective endocarditis	Disease	MESH:D004696
33986239	678	680	IE	Disease	MESH:D004696
33986239	712	715	HIV	Species	12721
33986239	716	723	patient	Species	9606
33986239	764	767	HIV	Species	12721
33986239	795	798	man	Species	
33986239	837	856	shortness of breath	Disease	MESH:D004417
33986239	872	877	cough	Disease	MESH:D003371
33986239	895	903	weakness	Disease	MESH:D018908
33986239	950	974	congestive heart failure	Disease	MESH:D006333
33986239	976	1013	chronic obstructive pulmonary disease	Disease	MESH:D029424
33986239	1019	1042	end-stage renal disease	Disease	MESH:D007676
33986239	1133	1143	hemorrhage	Disease	MESH:D006470
33986239	1255	1265	hemorrhage	Disease	MESH:D006470
33986239	1359	1375	ischemic lesions	Disease	MESH:D017202
33986239	1420	1444	mitral valve vegetations	Disease	MESH:D008944
33986239	1457	1473	ischemic lesions	Disease	MESH:D017202
33986239	1478	1482	cSAH	Disease	MESH:D013345
33986239	1493	1516	infectious endocarditis	Disease	MESH:D004696
33986239	1559	1569	vancomycin	Chemical	MESH:D014640
33986239	1574	1597	piperacillin-tazobactam	Chemical	MESH:D000077725
33986239	1610	1617	patient	Species	9606
33986239	1717	1721	cSAH	Disease	MESH:D013345
33986239	1735	1757	Infective endocarditis	Disease	MESH:D004696
33986239	1808	1812	cSAH	Disease	MESH:D013345
33986239	1854	1870	ischemic lesions	Disease	MESH:D017202
33986239	1920	1924	cSAH	Disease	MESH:D013345
33986239	1932	1934	IE	Disease	MESH:D004696
33986239	1935	1942	patient	Species	9606
33986239	1992	1995	HIV	Species	12721
33986239	2105	2109	cSAH	Disease	MESH:D013345
33986239	2125	2127	IE	Disease	MESH:D004696
33986239	Negative_Correlation	MESH:D000077725	MESH:D006470
33986239	Negative_Correlation	MESH:D014640	MESH:D008944
33986239	Negative_Correlation	MESH:D000077725	MESH:D004417
33986239	Negative_Correlation	MESH:D014640	MESH:D006470
33986239	Negative_Correlation	MESH:D000077725	MESH:D013345
33986239	Negative_Correlation	MESH:D000077725	MESH:D017202
33986239	Negative_Correlation	MESH:D014640	MESH:D004417
33986239	Negative_Correlation	MESH:D014640	MESH:D017202
33986239	Negative_Correlation	MESH:D014640	MESH:D003371
33986239	Negative_Correlation	MESH:D014640	MESH:D004696
33986239	Negative_Correlation	MESH:D014640	MESH:D013345

